P041 the Gut-selective, Orally Administered, Pan-jak Inhibitor Td-1473 Demonstrates Favorable Safety, Tolerability, Pharmacokinetic, and Signal for Clinical Activity in Subjects With Moderately-to-severely Active Ulcerative Colitis